Rational approach to treatment of moyamoya disease in childhood

K Ikezaki1

  • 1Department of Neurosurgery, Neurological Institute, Faculty of Medicine, Kyushu University, Fukuoka, Japan. nobu@ns.med.kyushu-u.ac.jp

Insights

Early diagnosis and treatment of moyamoya disease in children are crucial. Evaluating cerebral perfusion reserve guides surgical indications, and noninvasive magnetic resonance angiography aids follow-up, improving patient outcomes.

Area of Science:

  • Pediatric Neurology
  • Neurosurgery
  • Radiology

Background:

  • Moyamoya disease in children necessitates early intervention to prevent cognitive and physiological deficits.
  • Current management strategies in Japan focus on preoperative assessment and noninvasive follow-up.

Purpose of the Study:

  • To report on the current treatment of childhood moyamoya disease in Japan.
  • To detail preoperative evaluation methods for surgical indications.
  • To describe the role of magnetic resonance angiography in noninvasive follow-up.

Main Methods:

  • Review of treatment approaches for childhood moyamoya disease in Japan.
  • Evaluation of cerebral perfusion reserve using positron emission tomography (PET) or single photon emission tomography (SPECT) with acetazolamide or CO2 challenge.
  • Follow-up assessment using magnetic resonance angiography (MRA).

Main Results:

  • Approximately 20% of pediatric moyamoya disease patients were managed medically or observed.
  • Surgical interventions included single indirect bypass (30%), combined direct/indirect bypass (20%), and multiple indirect bypass (18%).
  • Postoperative improvements in cerebral perfusion reserve correlated better with reduced ischemic attacks than with collateral formation.

Conclusions:

  • Cerebral circulation and metabolism evaluation are vital for understanding moyamoya disease and optimizing treatment.
  • Reduced perfusion reserve is a key surgical indication.
  • Noninvasive MRA offers advantages for follow-up compared to conventional angiography, avoiding general anesthesia.

Related Concept Videos

Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...